September 3
9.30 - 12.30 AM (UTC+1)
University of Surrey, Stag Hill (Guildford, UK)
Join us in Guildford
The IST Innovation Forum is an educational medical platform designed to share expert insights, foster scientific exchange, and encourage the generation of new ideas.
The programme includes a roundtable of IITs, interactive group workshops, and presentations of innovative proposals.
Further details will be shared upon registration.
.jpg)
The topic
Genitourinary (GU) cancers, including prostate, bladder, and kidney cancers, remain among the most common and impactful malignancies worldwide, accounting for more than 2 million new cases and over 800,000 deaths each year. Despite major advances in diagnosis and treatment, many patients still face significant unmet needs, highlighting the continued need for innovation, multidisciplinary collaboration, and personalized therapeutic approaches. The rapidly evolving landscape of GU oncology offers new opportunities to improve outcomes and quality of life for patients affected by these life-changing diseases.
Investigator‑initiated trials (IITs) let us test smart combinations, sequences, and biomarker‑driven strategies that come directly from day‑to‑day clinical questions.
At MEDSIR, we team up with leading GU investigators and industry to turn those questions into well‑designed studies that generate evidence and, ultimately, better options for our patients.
Mentors of the Forum
Share your oncology clinical trial idea and travel to IIT Innovation Forum Urological Malignancies in Guildford with MEDSIR
Who can participate?
-
Clinical and translational oncology researchers.
-
Physicians and other healthcare professionals involved in clinical trials.
If you work in oncology and have a clinical trial idea, we would like to hear from you.
.png)
What are we looking for?
-
Oncology clinical trial ideas with the potential to improve clinical practice.
-
Proposals that are realistic from a regulatory and operational standpoint.
-
Innovative designs in patient selection, endpoints, biomarkers or data use.
-
Studies aligned with the independent and collaborative research model promoted by MEDSIR.
Your proposal should be submitted as a high-level synopsis and must not include patient personal data or confidential third-party information.
What is the prize?
The best ideas will receive a travel grant to attend IIT Innovation Forum Urological Malignancies in Guildford (United Kingdom).
If you are a healthcare professional, the grant will be managed in compliance with applicable transparency rules, including Farmaindustria, EFPIA and your institution’s internal policies.
MEDSIR will cover transportation up to a maximum amount of EUR 500.
MEDSIR can support the documentation of your participation and any related transfer of value.
How does it work?
-
Complete the online form with your contact details and institutional affiliation.
-
Describe your oncology clinical trial idea using the submission guidelines provided.
-
Our scientific committee will review the proposals based on quality, innovation and feasibility criteria.
-
MEDSIR will contact the winning participant directly and announce the result through its corporate channels.
-
At the IST Forum, selected participants will develop their ideas in group workshops with mentors, shaping them into concepts with real potential.
Participation is free of charge and does not create any obligation to enter into a future collaboration. If a proposal is of interest, MEDSIR may explore potential co-development paths with you and/or your institution.
Transparency, compliance and meaningful collaboration
MEDSIR organizes and funds this Contest directly. If you are a Healthcare Professional, your participation and, where applicable, acceptance of the prize must comply with the laws applicable to you, including any legal requirements relating to transparency, conflicts of interest or the receipt of grants or in-kind benefits.
Where required by applicable law, MEDSIR may request evidence of any necessary internal approvals or notifications, notify your institution of the award of the prize or disclose information relating to the prize. MEDSIR may withhold or revoke the prize where this is necessary to avoid a breach of applicable law.
Participation in the Contest does not create any obligation to enter into a future collaboration. If a proposal is of interest, MEDSIR may explore potential next steps with you or your institution under separate arrangements.
If you have any questions about conflicts of interest, institutional approvals or transparency requirements, please contact us at info@medsir.org before submitting your proposal.
About MEDSIR
A new model for collaborative research in clinical oncology
MEDSIR has more than a decade of experience developing strategic clinical trials in oncology, by combining the medical knowledge of our KOLs network, with a multidisciplinary expertise in clinical trials. Our innovative strategies help transform oncology ideas into high-impact collaborative trials that address unmet clinical needs while supporting the development and positioning of promising therapeutic approaches.
"
WE WANT TO IMPROVE THE LIVES OF CANCER PATIENTS BY ENSURING THEY HAVE ACCESS TO THE BEST TREATMENT OPTIONS FOR THEIR DISEASE.
